1. Home
  2. CRTO vs IVA Comparison

CRTO vs IVA Comparison

Compare CRTO & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$17.24

Market Cap

923.5M

ML Signal

HOLD

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.90

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
IVA
Founded
2005
2011
Country
France
France
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.5M
1.1B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CRTO
IVA
Price
$17.24
$4.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
10
Target Price
$34.00
$16.20
AVG Volume (30 Days)
467.3K
654.9K
Earning Date
05-06-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
38.95
N/A
EPS
0.37
N/A
Revenue
$2,296,692,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.54
$751.20
P/E Ratio
$45.86
N/A
Revenue Growth
27.65
N/A
52 Week Low
$15.58
$3.35
52 Week High
$25.29
$7.98

Technical Indicators

Market Signals
Indicator
CRTO
IVA
Relative Strength Index (RSI) 41.33 62.61
Support Level $16.36 $4.86
Resistance Level $19.55 $4.94
Average True Range (ATR) 0.74 0.16
MACD -0.07 0.00
Stochastic Oscillator 24.55 84.91

Price Performance

Historical Comparison
CRTO
IVA

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: